01 1Olon SPA
01 1DKSH Korea Co., Ltd.
01 1Mefloquine hydrochloride
01 1Italy
Registrant Name : DKSH Korea Co., Ltd.
Registration Date : 2022-09-28
Registration Number : 20220928-209-J-1371
Manufacturer Name : Olon SPA
Manufacturer Address : VIA LIVELLI, 1(loc. FRAZIONE MAIRANO) - 26852 CASALETTO LODIGIANO (LO), Italy
47
PharmaCompass offers a list of Mefloquine API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, and more, enabling you to easily find the right Mefloquine manufacturer or Mefloquine supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Mefloquine manufacturer or Mefloquine supplier.
A Lariam manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Lariam, including repackagers and relabelers. The FDA regulates Lariam manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Lariam API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Lariam manufacturers with USDMF, JDMF, KDMF, CEP, GMP, and COA related information on PhamaCompass.
A Lariam supplier is an individual or a company that provides Lariam active pharmaceutical ingredient (API) or Lariam finished formulations upon request. The Lariam suppliers may include Lariam API manufacturers, exporters, distributors and traders.
click here to find a list of Lariam suppliers with USDMF, JDMF, KDMF, CEP, GMP, and COA related information on PharmaCompass.
In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a Lariam Drug Master File in Korea (Lariam KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Lariam. The MFDS reviews the Lariam KDMF as part of the drug registration process and uses the information provided in the Lariam KDMF to evaluate the safety and efficacy of the drug.
After submitting a Lariam KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Lariam API can apply through the Korea Drug Master File (KDMF).
click here to find a list of Lariam suppliers with KDMF on PharmaCompass.
